GPT-Rosalind
GPT-Rosalind is a frontier reasoning model for biology and drug discovery, available to qualified customers through trusted access.
First in a life-sciences model series tuned for tool use over chemistry, protein engineering and genomics, with a free Codex plugin connecting 50+ scientific tools. Customers include Amgen, Moderna, Novo Nordisk and Thermo Fisher. A GPT-Rosalind-5.5 system card followed 2026-06-03.
- Date
- Thursday, 16 April 2026
- Lab
- OpenAI
- Kind
- model
- Access
- research preview
- Price
- trusted-access program; API $5/$25 per 1M tokens (changelog, 2026-09-08)
Domain-specialized models gated by access program mark a shift from one general model to trust-tiered deployments.
Sources
- openai.com/index/introducing-gpt-rosalind/
- deploymentsafety.openai.com/gpt-rosalind-5-5/
- developers.openai.com/api/docs/changelog
This record was checked against its sources on 6 October 2026. How we check